These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 31693057)

  • 1. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
    Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
    JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
    Olivotto I; Maron BJ; Tomberli B; Appelbaum E; Salton C; Haas TS; Gibson CM; Nistri S; Servettini E; Chan RH; Udelson JE; Lesser JR; Cecchi F; Manning WJ; Maron MS
    J Am Coll Cardiol; 2013 Jul; 62(5):449-57. PubMed ID: 23643593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry.
    Maurizi N; Antiochos P; Owens A; Lakdwala N; Saberi S; Russell MW; Fumagalli C; Skalidis I; Lin KY; Nathan AS; De Feria Alsina A; Reza N; Stendahl JC; Abrams D; Semsarian C; Clagget B; Lampert R; Wheeler M; Parikh VN; Ashley E; Michels M; Rossano J; Ryan TD; Ingles J; Ware J; Ho CY; Helms AS; Day SM; Olivotto I
    Circulation; 2024 Oct; 150(17):1377-1390. PubMed ID: 39355918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
    Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
    Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.
    Goldstein SA; Kennedy KF; Friedman DJ; Al-Khatib SM; Wang A
    J Am Heart Assoc; 2023 Aug; 12(16):e029293. PubMed ID: 37586066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.
    Maurizi N; Passantino S; Spaziani G; Girolami F; Arretini A; Targetti M; Pollini I; Tomberli A; Pradella S; Calabri GB; Vinattieri V; Bertaccini B; Leone O; De Simone L; Rapezzi C; Marchionni N; Cecchi F; Favilli S; Olivotto I
    JAMA Cardiol; 2018 Jun; 3(6):520-525. PubMed ID: 29710196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
    Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
    Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
    Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
    Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
    Shirani J; Aurshiya R; Elshaikh A; Olenchock SA; Rowin EJ; Maron MS; Maron BJ
    Am J Cardiol; 2021 Mar; 142():130-135. PubMed ID: 33279482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
    Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sex on clinical outcomes of hypertrophic cardiomyopathy in Singapore.
    Li TY; Yeo S; Ngiam NJ; Lee CH; Low TT; Lim YC; Evangelista LKM; Lee EC; Sari NY; Yeo TC; Yip JW; Poh KK; Kong WK; Lin W; Sia CH; Wong RC
    Ann Acad Med Singap; 2023 Jul; 52(7):348-355. PubMed ID: 38904500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic cardiomyopathy: a retrospective cohort study.
    Wang Y; Gao W; Han X; Jiang J; Sandler B; Li X; Zema C
    J Med Econ; 2023; 26(1):1495-1506. PubMed ID: 37902966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography.
    Masri A; Pierson LM; Smedira NG; Agarwal S; Lytle BW; Naji P; Thamilarasan M; Lever HM; Cho LS; Desai MY
    Am Heart J; 2015 May; 169(5):684-692.e1. PubMed ID: 25965716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.
    Yazaki K; Suzuki A; Shiga T; Minami Y; Arai K; Ashihara K; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2021 Feb; 21(1):106. PubMed ID: 33607967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.